Profiling Heparan Sulfate Proteoglycans in Ovarian Carcinoma by Andrew R. Clamp, Gordon C. Jayson

Get full text

Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. by Claire L Cole, Steen U Hansen, Marek Baráth, Graham Rushton, John M Gardiner, Egle Avizienyte, Gordon C Jayson

Get full text

Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo. by Egle Avizienyte, Claire L Cole, Graham Rushton, Gavin J Miller, Antonella Bugatti, Marco Presta, John M Gardiner, Gordon C Jayson

Get full text

The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors by Margherita Carucci, Andrew Clamp, Cong Zhou, Chris Hurt, Rosalind Glasspool, Phillip J. Monaghan, Sally Thirkettle, Michael Wheatley, Madia Mahmood, Monica Narasimham, Tracy Cox, Hilary Morrison, Susan Campbell, Annmarie Nelson, Daniella Holland-Hart, Noreen Hopewell-Kelly, Abin Thomas, Catharine Porter, Magdalena Slusarczyk, Alys Irving, Caroline Dive, Richard Adams, Gordon C. Jayson

Get full text